Terpyridine platinum compounds induce telomere dysfunction and chromosome instability in cancer cells
Terpyridine platinum compounds induce telomere dysfunction and chromosome instability in cancer cells |
|
https://doi.org/10.18632/oncotarget.28020
Nikolai Petrov,
Hee-Sheung Lee,
Mikhail Liskovykh,
Marie-Paule Teulade-Fichou,
Hiroshi Masumoto,
William C. Earnshaw,
Yves Pommier,
Vladimir Larionov,
and Natalay Kouprina
|
| 1444-1456 |
RNA expression differences in prostate tumors and tumor-adjacent stroma between Black and White Americans
RNA expression differences in prostate tumors and tumor-adjacent stroma between Black and White Americans |
|
https://doi.org/10.18632/oncotarget.28024
Farah Rahmatpanah,
Gabriela De Robles,
Michael Lilly,
Thomas Keane,
Vinay Kumar,
Dan Mercola,
Pavneet Randhawa,
and Michael McClelland
|
| 1457-1469 |
Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis
Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis |
|
https://doi.org/10.18632/oncotarget.28011
Reza Bayat Mokhtari,
Bessi Qorri,
Narges Baluch,
Angelo Sparaneo,
Federico Pio Fabrizio,
Lucia Anna Muscarella,
Albina Tyker,
Sushil Kumar,
Hai-Ling Margaret Cheng,
Myron R. Szewczuk,
Bikul Das,
and Herman Yeger
|
| 1470-1489 |
The impact of neoadjuvant concurrent chemoradiation on exosomal markers (CD63 and CD9) expression and their prognostic significance in patients with rectal adenocarcinoma
The impact of neoadjuvant concurrent chemoradiation on exosomal markers (CD63 and CD9) expression and their prognostic significance in patients with rectal adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.28025
Moh’d Khushman,
Pranitha Prodduturvar,
Wadad Mneimneh,
Valeria Dal Zotto,
Shalla Akbar,
Leander Grimm,
Paul Rider,
John Hunter,
Omar Alkharabsheh,
Girijesh Kumar Patel,
Jesus C. Fabregas,
and Ajay P. Singh
|
| 1490-1498 |
Identification of miR-203a, mir-10a, and miR-194 as predictors for risk of lymphovascular invasion in head and neck cancers
Identification of miR-203a, mir-10a, and miR-194 as predictors for risk of lymphovascular invasion in head and neck cancers |
|
https://doi.org/10.18632/oncotarget.28022
Moumita Karmakar,
Pei-Chun Lai,
Samiran Sinha,
Shannon Glaser,
and Sanjukta Chakraborty
|
| 1499-1519 |
JunD accentuates arecoline-induced disruption of tight junctions and promotes epithelial-to-mesenchymal transition by association with NEAT1 lncRNA
JunD accentuates arecoline-induced disruption of tight junctions and promotes epithelial-to-mesenchymal transition by association with NEAT1 lncRNA |
|
https://doi.org/10.18632/oncotarget.28026
Subarna Ghosh,
Priyanka Dey Talukdar,
Abhinandan Bhattacharjee,
Sarbani Giri,
Nitai Pada Bhattacharyya,
and Urmi Chatterji
|
| 1520-1539 |
Actionability evaluation of biliary tract cancer by genome transcriptome analysis and Asian cancer knowledgebase
Actionability evaluation of biliary tract cancer by genome transcriptome analysis and Asian cancer knowledgebase |
|
https://doi.org/10.18632/oncotarget.28021
Yuki Okawa,
Nobutaka Ebata,
Nayoung K.D. Kim,
Masashi Fujita,
Kazuhiro Maejima,
Shota Sasagawa,
Toru Nakamura,
Woong-Yang Park,
Satoshi Hirano,
and Hidewaki Nakagawa
|
| 1540-1552 |
Multidisciplinary clinics in prostate cancer
Multidisciplinary clinics in prostate cancer |
|
https://doi.org/10.18632/oncotarget.27984
Brian De,
Deborah A. Kuban,
and Chad Tang
|
| 1553-1554 |
Developing next generation immunomodulatory drugs and their combinations in multiple myeloma
Developing next generation immunomodulatory drugs and their combinations in multiple myeloma |
|
https://doi.org/10.18632/oncotarget.27973
Anjan Thakurta,
William E. Pierceall,
Michael D. Amatangelo,
Erin Flynt,
and Amit Agarwal
|
| 1555-1563 |
Correction: Oncogenic extracellular HSP70 disrupts the gap-junctional coupling between capillary cells
Correction: Oncogenic extracellular HSP70 disrupts the gap-junctional coupling between capillary cells |
|
https://doi.org/10.18632/oncotarget.28028
Dominique Thuringer,
Kevin Berthenet,
Laurent Cronier,
Gaetan Jego,
Eric Solary,
and Carmen Garrido
|
| 1564-1565 |
